Achieve Life Sciences Analyst Ratings and Price Targets | NASDAQ:ACHV

Comments

Achieve Life Sciences Inc Analyst Ratings

ACHVNASDAQ

Trade with Public

$4.20

0.071.69%

At close: Feb 13, 4:00 PM EST

$4.16

-0.0393-0.94%

After Hours: 6:34 PM EST

Overview News Earnings OptionsAnalyst RatingsInsider Trades Short Interest Stock Report

Consensus Rating¹

Buy

Highest Price Target¹

$20.00

Lowest Price Target¹

$11.00

Consensus Price Target¹

$15.00

Achieve Life Sciences Analyst Ratings and Price Targets | NASDAQ:ACHV | Benzinga

Achieve Life Sciences Inc has a consensus price target of $15 based on the ratings of 7 analysts. The high is $20 issued by Raymond James on September 27, 2024. The low is $11 issued by Oppenheimer on August 15, 2024. The 3 most-recent analyst ratings were released by Citizens, HC Wainwright & Co., and Rodman & Renshaw on November 25, 2025, August 21, 2025, and November 14, 2024, respectively. With an average price target of $14.33 between Citizens, HC Wainwright & Co., and Rodman & Renshaw, there's an implied 244.49% upside for Achieve Life Sciences Inc from these most-recent analyst ratings.

Analyst Trends and Forecast

Aug 25

Nov 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Analyst Firms Making Recommendations¹

Citizens

HC Wainwright & Co.

Rodman & Renshaw

Raymond James

Oppenheimer

¹calculated from analyst ratings

Analyst Ratings for Achieve Life Sciences

	Buy Now						Get Alert
11/25/2025	Buy Now	356.65%	Citizens	→ $19	Initiates	→ Market Outperform	Get Alert
08/21/2025	Buy Now	188.41%	HC Wainwright & Co.	→ $12	Initiates	→ Buy	Get Alert
11/14/2024	Buy Now	188.41%	Rodman & Renshaw	→ $12	Initiates	→ Buy	Get Alert
09/27/2024	Buy Now	380.69%	Raymond James	→ $20	Initiates	→ Strong Buy	Get Alert
08/15/2024	Buy Now	164.38%	Oppenheimer	$11 → $11	Reiterates	Outperform → Outperform	Get Alert
05/13/2024	Buy Now	164.38%	Oppenheimer	$18 → $11	Maintains	Outperform	Get Alert
04/17/2024	Buy Now	380.69%	JonesTrading	→ $20	Initiates	→ Buy	Get Alert
04/01/2024	Buy Now	332.62%	Oppenheimer	$18 → $18	Reiterates	Outperform → Outperform	Get Alert
03/05/2024	Buy Now	164.38%	Lake Street	$19 → $11	Maintains	Buy	Get Alert
12/12/2023	Buy Now	332.62%	Oppenheimer	$21 → $18	Maintains	Outperform	Get Alert
05/31/2023	Buy Now	356.65%	Lake Street	$22 → $19	Maintains	Buy	Get Alert
05/10/2023	Buy Now	428.76%	Lake Street	→ $22	Maintains	Buy	Get Alert
03/17/2023	Buy Now	308.59%	Oppenheimer	→ $17	Reiterates	→ Outperform	Get Alert

FAQ

What is the target price for Achieve Life Sciences (ACHV) stock?

The latest price target for Achieve Life Sciences (NASDAQ:ACHV) was reported by Citizens on November 25, 2025. The analyst firm set a price target for $19.00 expecting ACHV to rise to within 12 months (a possible 356.65% upside). 2 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Achieve Life Sciences (ACHV)?

The latest analyst rating for Achieve Life Sciences (NASDAQ:ACHV) was provided by Citizens, and Achieve Life Sciences initiated their market outperform rating.

When was the last upgrade for Achieve Life Sciences (ACHV)?

There is no last upgrade for Achieve Life Sciences

When was the last downgrade for Achieve Life Sciences (ACHV)?

There is no last downgrade for Achieve Life Sciences.

When is the next analyst rating going to be posted or updated for Achieve Life Sciences (ACHV)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Achieve Life Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Achieve Life Sciences was filed on November 25, 2025 so you should expect the next rating to be made available sometime around November 25, 2026.

Is the Analyst Rating Achieve Life Sciences (ACHV) correct?

While ratings are subjective and will change, the latest Achieve Life Sciences (ACHV) rating was a initiated with a price target of $0.00 to $19.00. The current price Achieve Life Sciences (ACHV) is trading at is $4.16, which is within the analyst’s predicted range.